JULIA BALCOM: Open Payments
NPI 1194153494 · DALLAS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $91 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| ABBVIE INC. | 1 | $26 |
| Abbott Laboratories | 1 | $14 |
Products named: EVENITY, UBRELVY, SHINGRIX, BEXSERO, ID NOW INSTRUMENT.
Industry payments across OR — which companies pay providers there.
